Article · Health
Breast arterial calcification, or BAC, can show up on routine mammograms and may signal higher cardiovascular risk. The finding is promising, but not yet a stand-alone diagnosis or treatment trigger.
October 9, 2026
Article · Health
Federal advisers have opened the door to temporary access for several unapproved peptide products, even as FDA warnings continue to stress that compounded versions are not reviewed for safety, effectiveness…
October 9, 2026
Article · Health
Research and recent reporting point to a familiar but still unresolved problem in breast cancer care: one-size-fits-all screening and treatment can miss important differences in risk, tumor biology, and overall…
October 9, 2026
Article · Health
New AI-powered breast cancer risk tools are moving beyond the clinic and into patient-facing apps, but experts still urge caution about accuracy, equity, and how results should guide screening.
October 9, 2026
Article · Health
The FDA says its ongoing safety review of mifepristone will continue into next year, keeping one of the nation’s most closely watched drug-policy fights in motion.
October 9, 2026
Article · Health
AARP’s latest caregiving guidance highlights why medication lists in long-term care need regular review—especially for drugs linked to confusion, falls, and other side effects.
October 8, 2026
Article · Health
An AP report spotlights the rising strain on family caregivers and why sleep, support, and respite can help protect health—especially for adults 45 and older.
October 8, 2026
Article · Health
The FDA says its safety review of mifepristone will continue into next year, keeping attention on a drug that is widely used for abortion and miscarriage care.
October 7, 2026
Article · Health
A reported death tied to delayed COPD medication highlights how coverage barriers can disrupt treatment for adults with chronic lung disease—especially after age 45.
October 7, 2026